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Abstract
Neisseria meningitidis is a nasopharyngeal commensal of humans which occasionally invades the blood to cause
septicaemia. The transcriptome of N. meningitidis strain MC58 grown in human blood for up to 4 hours was determined and
around 10% of the genome was found to be differentially regulated. The nuo, pet and atp operons, involved in energy
metabolism, were up-regulated, while many house-keeping genes were down-regulated. Genes encoding protein
chaperones and proteases, involved in the stress response; complement resistant genes encoding enzymes for LOS
sialylation and biosynthesis; and fHbp (NMB1870) and nspA (NMB0663), encoding vaccine candidates, were all up-regulated.
Genes for glutamate uptake and metabolism, and biosynthesis of purine and pyrimidine were also up-regulated. Blood
grown meningococci are under stress and undergo a metabolic adaptation and energy conservation strategy. The
localisation of four putative outer membrane proteins encoded by genes found to be up-regulated in blood was assessed
by FACS using polyclonal mouse antisera, and one (NMB0390) showed evidence of surface expression, supporting its
vaccine candidacy.
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Introduction
The Gram-negative bacterium Neisseria meningitidis is a human
commensal colonizing the nasopharynx, which occasionally
invades the bloodstream of susceptible individuals (mainly infants
and young people) to cause diseases with substantial morbidity and
mortality – septicaemia and meningitis [1,2]. In the course of
invasive infection, meningococci evade innate immune responses –
in particular the complement system – and survive in the face of
limited availability of micronutrients, such as iron, that are
sequestered by the host. Survival in the hostile environment of
blood requires the meningococcus to differentially regulate the
expression of its genes [3–6].
Animals such as the mouse and rat have been widely used as
convenient models to investigate which meningococcal genes
contribute to bacterial survival in blood, and so to virulence. For
example, 73 meningococcal genes that contribute to survival in the
blood have been identified using an infant rat model [7]. However,
major differences between the nature of meningococcal infection
in such animals and in man mean that there must be important
reservations in interpreting such studies. To address these,
‘‘bridging studies’’ using human plasma, serum and blood have
been undertaken: for example, the serum bactericidal assay is the
mainstay for vaccine testing [8]. A whole human blood ex vivo
meningococcal infection model has been developed to investigate
vaccine-induced serum bactericidal activity and the contribution
that blood cells play in controlling infection [9,10]. A single study
has evaluated the transcriptome of meningococci grown in human
serum [11], and one further study, published during the
preparation of this manuscript, has investigated the transcriptome
in blood-grown organisms [12].
Like the authors of this last-cited work, we have sought to
determine the transcriptome of N. meningitidis when grown in non-
bactericidal whole human blood (the natural condition of
meningococcal septicaemia in infants), with a view to identifying
genes that may be important for bacterial survival and those
encoding potential vaccine candidates, identified by being
upregulated during bacteraemia and exposed on the bacterial
surface. Our results are broadly in agreement with those of
Enrique et al. [12]. We have delineated aspects of the bacterial
stress response induced by whole blood, demonstrated up-
regulation of genes encoding current key candidate vaccine
antigens –fHbp (factor H binding protein) and NHBP (neisserial
heparin binding antigen), and identified further candidates with
comparable desirable properties. Among these, we have identified
NMB0390 in particular as a sequence-conserved and potentially
surface exposed protein, expressed in the course of this model of
bloodstream infection, that we consider merits further study as a
potential vaccine candidate.
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Characterization of a whole human blood model of
meningococcal infection for transcriptional studies
We sought to establish a meningococcus-human blood co-
cultivation model, in which N. meningitidis grows in fresh human
blood at an infection level comparable to that found in patients
with meningococcal sepsis [13], from which we could recover
sufficient bacterial RNA for transcriptome analysis without
amplification. Two healthy adults were identified whose blood
had no bactericidal activity against N. meningitidis serogroup B
strain MC58 – so called non-killers [14].
We began by determining an infection load, representative of
bacterial numbers found in septicaemic patients, that would yield
sufficient RNA (5 mg) for direct labelling without prior amplifica-
tion, a step known to introduce transcriptome bias [15].
Employing real-time PCR technology Ovstebo et al. [13] found
an average of 10
7 CFU (range 10
5–10
9) meningococci per ml of
blood from paediatric patients with septic shock. Exploring within
this range, in experiments using bactericidal and non-bactericidal
fresh whole blood, we found that using 10
5–10
6 CFU per ml
inoculum we were not able to obtain a sufficient amount of
bacterial RNA for direct labelling. Conversely, on using an
inoculum of 10
9 CFU per ml, although sufficient amounts of RNA
were obtained, meningococci grew in a donor’s blood that was
otherwise bactericidal when using 10
7 per ml inoculum (Figure 1A).
This suggests that normally adequate meningococcal killing
mechanisms in this donor’s blood were overwhelmed by the
presence of high numbers of bacteria. However, using 10
7 per ml
inoculum resulted in meningococcal numbers increasing steadily
over the 240 minute time course (Figure 1B) in contrast to the
finding in experiments in which non-killer’s blood was doped with
10% killer’s plasma (Figure 1C). Using 10
7 per ml inoculum, 5 mg
or more of meningococcal RNA could be obtained from aliquots
harvested at each time point (0, 20, 40, 60, 90 and 240 min), with
very low levels of human RNA contamination (Figure S1).
To assess the impact of relatively heavy bacterial infection on
the chemical composition of the blood, concentrations of major
electrolytes (sodium, potassium, calcium), pH and oxygen
concentration, iron, glucose and lactate were determined at each
experimental time point. In addition, complement C3 and total
haemolytic complement (CH50) were assayed. Electrolytes, iron
and oxygen concentration, and pH, remained in the acceptable
range for healthy humans, whether or not bacteria were present
(data not shown). Lactate concentration rose, and glucose
concentration fell, over the course of the experiments, whether
or not bacteria were present. Blood glucose remained in the
normal range for fasting humans (3–5.5mmol/L) at all time points
except 240 minutes. There was no evidence of complement
consumption (as might be reflected by fall in concentrations of C3
and CH50) in the course of the experiment (Table 1).
To assess reproducibility of the model, identical experiments
were run 4–6 times (biological replicates). The transcriptome of
each biological replicate at each time point was compared with
that of the first (Rep1) obtained in each group to establish that
transcriptional profiles at each time point up to and including
90 min were highly reproducible (correlation .0.91) (Table S1).
However, greater variation appeared in transcriptional profiles by
240 min (correlation 0.72–0.94).
Overall relationship between transcriptomes of each
time point groups
The transcriptome of the T=0min samples (aliquots processed
immediately following addition of bacteria to blood) represents
early exponential bacterial growth (following 4 hours growth of
meningococci freshly restreaked from an overnight culture on to
prewarmed fresh sGC plates). To develop a representation of
variation over time of the transcriptome of meningococci growing
in blood, the transcriptome of Rep1 at the T=0min time point
(Rep1
T=0) was compared with all the others. As the period of co-
cultivation increased, the correlation fell, indicating a change in
the transcriptional profile from as early as 20 min, most striking by
240 min (Table 2). Correlation analysis revealed 58–82% similar-
ity of the Rep1
T=0 transcriptome to those of other time points.
Transcriptome profiles were consolidated for each time point,
and variation between profiles at different time points was
analysed using Principal Component Analysis (PCA) and displayed
in a 2D plot (Figure 2). This showed that the meningococcal
Figure 1. Growth of meningococci (strain MC58) in whole
human blood. Meningococcal growth is shown by CFU obtained at
time points after initial inoculation. Error bars indicate SEM of biological
replicates. (A) Growth of meningococci in donor C blood expressed as
percent of initial inoculum, 10
7 (dashed line) or 10
9 (solid line) CFU per
ml of blood. (B) Growth of meningococci in donor A (solid line) and B
(dashed line) blood. (C) Growth of meningococci in donor A (solid line)
and C (dashed line) blood, and donor A blood ‘‘doped’’ with 10% of
donor C plasma (dotted line).
doi:10.1371/journal.pone.0039718.g001
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were tightly clustered, suggesting little transcriptional change
within this time span. However, major differences between the
T=0min transcriptome and those from T=20min, 40min and
60min were apparent (as indicated by substantial shift along the
PCA component 2 axis). At later time points it appeared that
transcription of a different set of genes was altered, indicated by a
progressive shift along the PCA component 1 axis.
Metabolic adaptation and energy conservation
Lists of differentially expressed meningococcal genes were
generated by comparing expression data for each co-cultivation
time point with that of T=0min using the same statistical cut-off
(1.5-fold change and fault discovery rate p,0.01). In general, the
numbers of genes that were up- or down-regulated at each time
point were similar, comprising 8–14% of the total genome (2113
ORFs used in array design). The only exception was down-
regulated genes for samples at T=240min which comprised 20%
of the total genome (Table S2). When grouped into conventional
functional categories, the most differentially expressed genes were
energy metabolism, protein synthesis and hypothetical. In the
energy metabolism group, many genes encoding enzymes for ATP
production were up-regulated. Twelve out of 14 genes of the nuo
operon encoding subunits for the NADH dehydrogenase complex
I [16] were up-regulated at multiple time points (Table S3). The
pet operon (petA, petB and petC) encoding the cytochrome c
reductase complex III was also up-regulated at multiple time
points (Table S3). Four of 8 genes in the atp operon encoding
ATPase complex V, which produces ATP, were up-regulated at
most time points. However, at T=240min 3 of the 4 genes of the
atp operon were down-regulated (Table S3).
Most genes in the protein synthesis group were up-regulated at
early time points and down-regulated at the T=240min time
point (Figure 3). Further analysis indicated that this difference
reflected the differential expression of genes encoding ribosomal
proteins. Forty-seven out of 54 ribosomal protein genes were
differentially regulated at one or more time points. The trend of
differential regulation showed coordinated up-regulation at earlier
time points (from T=20min to T=90min) and down-regulation
at T=240min (Figure 4, for fold changes see Table S3). Two
other groups of genes encoding essential ‘‘house-keeping’’
enzymes/proteins were also down-regulated. These were the
DNA gyrase genes gyrA and gyrB, which were both down-regulated
at 40–240min, and cell division genes minC, minD, minE,
Table 1. Measurements of blood components sampled at time points during blood and N. meningitidis co-cultivation.
Blood donor Addition of bacteria Bactericidal activity
1 Time point Glucose (mmol/l) Lactate (mmol/l) C3 (g/l) CH50 (U/ml)
A No n/a 0 4.6 2.7 1.00 nd
A No n/a 90 3.7 4.9 0.99 34
A No n/a 240 1.9 8.8 1.05 33
A Yes Non-killer 90 3.4 4.9 1.00 30
A Yes Non-killer 240 1.2 7.9 1.06 26
A+C
2 Yes Killer 90 3.6 4.6 1.01 32
A+C
2 Yes Killer 240 1.8 8.9 1.07 30
C No n/a 0 5.3 1.6 1.08 41
C No n/a 90 3.8 4.5 1.08 nd
C No n/a 240 2.0 8.7 1.07 nd
C Yes Killer 90 3.5 3.9 1.08 42
C Yes killer 240 0.8 2.8 1.11 36
Normal range 3.0–5.5 0.5–2.2 0.7–1.7 23–46
1Bactericidal activities are defined by reduction of CFU, shown in Figure 1A and C.
2A+C: Blood from donor A with addition of plasma from donor C to 10%.
n/a: not applicable; nd: not determined.
doi:10.1371/journal.pone.0039718.t001
Table 2. Correlation of transcriptional patterns obtained from biological replicates (T=0min Rep 1 or Rep1
T=0is the base pattern).
Sample group name (co-cultivation time points)
Replicate number T=0min T=20min T=40min T=60min T=90min T=240min
Rep. 1 1 0.798 0.823 0.818 0.808 0.708
Rep. 2 0.959 0.781 0.803 0.807 0.781 0.689
Rep. 3 0.952 0.77 0.796 0.795 0.757 0.585
Rep. 4 0.946 0.749 0.795 0.79 0.722 0.575
Rep. 5 0.925 0.739 0.795 0.79 0.72 (0.32)
Rep. 6 N/A N/A 0.782 N/A 0.697 N/A
Correlation was calculated using GeneSpring (Agilent) microarray analysis software as described in Material and Methods.
doi:10.1371/journal.pone.0039718.t002
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multiple time points (Table S3). Taken together, these results
indicate that meningococci undergo a metabolic adaptation and
energy conservation strategy when growing in blood.
As the plasma concentration of lactate increased during the
course of co-cultivation, we examined the expression of meningo-
coccal genes involved in its transport and metabolism. The
observed change in lactate concentration was not reflected in
regulated expression of NMB0543 (lctP) encoding lactate perme-
ase, nor of NMB1377 (lldA) and NMB0901 (both encoding lactate
dehydrogenases).
Meningococcal genes contributing to complement
evasion are highly expressed in blood-grown organisms
LOS (lipooligosaccharide), as well as polysaccharide capsule,
has been established to be important factors contributing to
meningococcal survival in human blood [17–19], through
distancing activated complement components mediating opsono-
phagocytosis and complement-mediated killing away from the
bacterial surface. The contribution of LOS to serum resistance is
importantly enhanced by its sialylation which is catalysed by a-2,3-
sialyltransferase encoded by the gene lst (NMB0922). This gene
was found to be up-regulated at 20, 40, 60 and 240min (Table 3).
Other genes encoding enzymes involved in LOS biosynthesis (lgtA,
lgtB, lgtE, lgtF, and rfaK) were also found to be up-regulated at
various time points (Table 3). On the other hand, most genes
involved in capsular biosynthesis and transport were not found to
be significantly differentially up-regulated (Table S3).
fHbp (NMB1870) and nspA (NMB0663), encoding factor H
binding proteins [20,21], which reduce complement activation at
the bacterial surface and so contribute to meningococcal resistance
to complement killing, were up-regulated at various time points
between 20 and 90 min (Table S3).
Up-regulation of other known and potential virulence
genes promoting survival of meningococci in the human
host
Twenty-five out of 104 genes considered by Tettelin et al. [6] to
encode products contributing to meningococcal virulence were
found to be differentially expressed (predominantly up-regulated)
at most time points (Table 3). For example, mip, encoding
macrophage infectivity potentiator (NMB0995), was up-regulated
at all time points. The gonococcal homolog is important for N.
gonorrhoeae survival against macrophage killing [22]. Genes bfrA and
bfrB (encoding bacterioferritin subunits), which are implicated in
neisserial iron storage and protection against oxidative stress [23],
were up-regulated at most time points. The katA gene encoding
catalase was highly up-regulated at most time points. The
gonococcal homolog was shown to protect N. gonorrhoeae from
oxidative killing [24].
Genes NMB1962–1966 belonging to the operon encoding the
glutamate ABC transporter and accessory machinery [25] were all
Figure 2. Principal component analysis (PCA) of meningococcal
transcriptomes obtained at different blood co-cultivation time
points. The numbers in the plot represent the relative positions of
samples and co-cultivation time points. Dashed arrows represent the
passage of time.
doi:10.1371/journal.pone.0039718.g002
Figure 3. Schematic representation of the number of differentially regulated meningococcal genes. Genes were identified in blood co-
cultivation experiments at different time points, which are indicated by colour keys. Genes were classified into TIGR functional categories. Minus signs
indicate down-regulated gene number.
doi:10.1371/journal.pone.0039718.g003
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operation of this transporter has been implicated in meningococcal
resistance to killing in human blood and animal infection models
[26] and resistance to neutrophil killing [27], Consistent with
previous findings our results further highlight the importance of
this operon for survival of meningococci in blood.
Using Gene Set Enrichment Analysis (GSEA) [28], the genes in
the amino acid biosynthesis category were found to be significantly
enriched for all three time points identified by the programme, 20,
40 and 60 min (Table 4). Further analysis of the category
established that most genes in the glutamate families were up-
regulated (Table S3), included gdhA (NMB1710) and glnA
(NMB0359). gdhA, encoding glutamate dehydrogenase, has been
found to be essential for establishing systemic infection in an infant
rat model [29].
Purine, pyrimidine, nucleoside and nucleotide biosynthesis
genes were also identified as highly significantly enriched by
GSEA. Most genes encoding enzymes of the purine and
pyrimidine biosynthesis pathways were up-regulated at multiple
time points (Figure 5 and Table S3). While the contribution of
these genes to meningococcal virulence has not been established,
genes in the same pathways have been shown to be crucial for
survival of Escherichia coli, Salmonella enterica and Bacillus anthracis in
human blood [30].
The stress response is important for meningococcal
survival in blood
The up-regulation of genes with roles in promoting meningo-
coccal survival in adverse environments was anticipated to be part
of a more generalised stress response induced by bacterial
cultivation in blood. Attention was therefore focussed on further
genes encoding proteins implicated in the stress response.
The stress response proteins – ClpB, DnaK, DnaJ, GrpE,
GroEL and GroES – are proteases or chaperones that work in
concert to maintain correct folding of proteins [31]. The cognate
genes (clpB, dnaK, dnaJ, grpE, groEL and groES) were found to be up-
regulated at most time points (Table 5). Other protease encoding
genes that may substitute for clpB were found to be up-regulated at
multiple time points. These included lon, htpX, clpP and clpX, the
last two encoding a two component protease/chaperone complex
(Table 5). Components of the NMB1436-NMB1438 operon,
which was found to be important for protecting meningococci
from oxidative stress and promoting survival in mouse blood
model [32], were up-regulated at most time points (Table 5).
Candidate vaccine antigen genes: identification of up-
regulated genes encoding surface exposed proteins
Differential gene expression lists were interrogated for genes
encoding proteins identified as potential vaccine candidates. Of
the three principal antigenic components of the 4CMenB vaccine
currently in an advanced stage of development [33] NMB1870
(fHbp) and NMB2132 (NHBA) were up-regulated at 40 and
20 min, respectively, while NMB1994 (encoding NadA) was
down-regulated at most time points (Table S3). Genes encoding
other potential vaccine candidates such as nspA [20], mip
(NMB0995) [34] and opcA [35] were all found to be up-regulated
at multiple time points (Table S3).
We extended this line of enquiry to identify, for further study,
other genes encoding meningococcal proteins known or predicted
to be surface exposed which were upregulated during growth in
blood and that had not been identified previously as potential
vaccine candidates. For nine such genes (Table S3), meningococ-
cal RNA samples obtained from paired co-cultivation experiments
in blood from two donors were reverse-transcribed for real-time
RT-PCR (TaqMan technology) quantification. Positive correla-
tions were demonstrated between the results of microarray analysis
and real-time RT-PCR experiments (Figure 6).
Surface expression of potential vaccine candidates
Mouse polyclonal antibodies were successfully prepared against
the protein products of 4 of these 9 genes (NMB0390, NMB0563,
NMB1882 and NMB1961) expressed as recombinants in E. coli,
and used to assess surface expression experimentally. Increased
surface expression of NMB1882, NMB1961 and NMB0563 was
not demonstrated, but flow cytometric analysis using anti-
NMB0390 showed a progressively increased expression of this
protein from T=90min to T=240min on the surface of
meningococci (Figure 7). Although the cross-reactive signals from
the control serum obtained from PBS immunized mice also
appeared to be increased with time, the signal from the anti-
NMB0390 serum was much greater than that from the anti-PBS
serum at later time points: –the signal peaks from anti-NMB0390
and anti-PBS sera were further apart at T=240min compared to
Figure 4. Expression levels of ribosomal protein genes at
different co-cultivation time points (relative to T=0min). Each
differently coloured line represents one gene (identified in Table S3).
doi:10.1371/journal.pone.0039718.g004
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expression, and therefore potential vaccine candidacy, of
NMB0390 was induced by co-incubation with human blood.
An advantageous characteristic of a good vaccine candidate is a
high sequence conservation amongst isolates. Coding sequences
for homologues of NMB0390 (maltose phosphorylase) from a total
Table 3. Differentially expressed meningococcal genes encoding virulence factors* during blood co-cultivation compared with
T=0min samples (log2 ratio, p,0.01 with FDR).
Gene number Gene name Function Co-cultivation time points
20min 40min 60min 90min 240min
NMB0014 kdtA Octulosonic-acid transferase 0.851
NMB0018 pilE Major pilin 0.837 0.714 0.723
NMB0051 pilU Twitching motility protein 0.618 0.603 20.602
NMB0179 fabZ 3R-hydroxymyristoyl-ACP dehydratase 0.596 0.614
NMB0199 lpxB Lipid-A-disaccharide synthase 0.691 0.657
NMB0216 katA Catalase 2.656 2.750 3.301 2.483
NMB0393 Multidrug resistance protein 0.816
NMB0586 Putative adhesin 0.649
NMB0922 lst Alpha-2,3-sialyltransferase 1.159 0.809 0.913 0.686
NMB0926 Opacity protein 0.673 20.884
NMB0995 mip Macrophage infectivity potentiator 1.337 0.958 0.741 0.734 0.729
NMB1053 opcA Class 5 outer membrane protein 1.124 1.068
NMB1206 bfrB Bacterioferritin B 2.482 1.193 0.633 1.001
NMB1207 bfrA Bacterioferritin A 2.186 0.969 1.164
NMB1332 prc Carboxy-terminal peptidase 1.217
NMB1704 lgtF Beta-1,4-glucosyltransferase 0.960 0.844 0.884 0.760 0.806
NMB1705 rfaK Acetylglucosamine transferase 0.654 1.041
NMB1779 hemagglutinin/hemolysin 1.057
NMB1880 fetB2 Putative ABC transporter, periplasmic solute-
binding protein
1.233
NMB1882 TonB-dependent receptor 0.866
NMB1926 lgtE Lacto-N-neotetraose biosynthesis glycosyl
transferase
0.725
NMB1928 lgtB Lacto-N-neotetraose biosynthesis glycosyl
transferase
0.600
NMB1929 lgtA Lacto-N-neotetraose biosynthesis glycosyl
transferase
0.726 0.904 0.779 0.974
NMB1961 VacJ-related protein 0.742 0.691 0.721 0.634
NMB2132 Transferrin binding protein-related 0.661
*as listed by Tettelin et al. [6].
doi:10.1371/journal.pone.0039718.t003
Table 4. Significantly enriched* TIGR functional groups of differentially expressed meningococcal genes in response to blood co-
cultivation.
Functional group Co-cultivation time (min)
20 40 60
Amino acid biosynthesis Yes Yes Yes
Biosynthesis, cofactors, prosthetic and carriers Yes
Purines, pyrimidines, nucleosides and nucleotide biosynthesis Yes Yes Yes
Protein fate Yes Yes
Protein synthesis Yes Yes
Transcription Yes Yes
*Calculated using GSEA with FDR q-value ,0.25.
doi:10.1371/journal.pone.0039718.t004
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high degree of similarity ($97%). All translated proteins were 752
amino acids in length, and in all but two positions, just one or
other of two possible amino acids were found. Mutations were
sparsely scattered throughout the length of the protein (Table 6
and Figure 8).
Discussion
Transcriptional profiling offers new insights into mechanisms
that allow meningococci to survive in human blood, facilitating
formulation of new treatment and prevention strategies.
We have developed a whole human blood experimental system
to explore progressive changes in meningococcal gene expression
during septicaemia. Biochemical changes developing in the plasma
of blood incubated with gentle rocking in a 5% CO2–enriched
atmosphere even in the absence of meningococci defined a
practical limit of 4 hours for experiments, with reduced repro-
ducibility of transcriptomal results after 90 min (Table S1).
Replicates of 240 min showed greater variations (0.71–0.94) than
the replicates of other time points (91%–98%) (Table S1). Because
a stringent p value (0.01) cut off, together with Benjamini and
Hochberg error test, was applied to the analysis of samples of all
time points, the differences in variation should not impact on the
confidence of the genes being selected as differentially expressed.
However, 90 min represents ,3 generations of exponential
growth (Figure 1B), long enough for relevant transcriptional
changes to occur. Plasma lactate rose consistently in the course of
experiments, and while plainly this was not occurring by the same
mechanism of tissue ischaemia as seen in septic shock [36], the
experimental environment was the more similar to natural
meningococcal sepsis as a result.
Microarray technologies offer new opportunities to identify
genes or pathways contributing to a complex phenotype such as
virulence. Using GSEA [28], we were able to identify a group of
genes clustered on purine and pyrimidine nucleotide biosynthesis
pathways, which have not been reported previously for their
involvement in meningococcal virulence, although identified by
others as playing a key role in E. coli, S. enterica and B. anthracis
survivial in blood/serum [30]. Glutamine is the substrate for the
early stage of de novo biosynthesis of purines and pyrimidines.
Genes involved in assimilating glutamate from the environment,
and converting it to glutamine, were found to be up-regulated
during blood co-cultivation. Specific inhibitors of such pathways in
bacteria may prove useful as therapeutic agents.
Figure 5. Meningococcal purine and pyrimidine biosynthesis pathway deduced from KEGG pathway database [49]. Genes found to be
up-regulated are indicated (up). * indicates that PurB catalyzes conversion of SAICAR to IMP and IMP to AMP.
doi:10.1371/journal.pone.0039718.g005
Table 5. Differentially expressed meningococcal genes
encoding stress response proteins during blood co-cultivation
compared with T=0min samples (log2 ratio, p,0.01 with
FDR).
Gene
number
Gene
name Co-cultivation time points
20min 40min 60min 90min 240min
NMB0554 dnaK 1.785 1.507 0.986
NMB0561 grpE 0.864 2.397 1.828 1.316 1.564
NMB0059 dnaJ 1.598 1.180 1.060
NMB1972 groEL 2.462 2.260 1.516 1.316
NMB1973 groES 2.554 2.263 1.435
NMB1472 clpB 20.913 1.145 0.643
NMB1231 lon 1.968 1.629 1.006 20.747
NMB0822 htpX 1.034 0.991 1.064 0.712 0.734
NMB1312 clpP 0.961 0.794 0.715 1.472
NMB1428 clpX 0.782 0.627 0.823
NMB1436 0.866 1.017 1.259 0.642
NMB1437 1.324 1.309 1.626 1.025 0.896
NMB1438 1.254 1.344 1.487 1.118
doi:10.1371/journal.pone.0039718.t005
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study were in pathways relating to amino acid and protein
biosynthesis. In particular, ribosomal protein genes showed a
switch from up- to down-regulation at early compared to later co-
cultivation time points (Figure 3 and 4). This change in regulation
coincided with the switch of meningococcal growth from lag to
exponential phase (Figure 1B). The change in regulation may, we
speculate, reflect metabolic adaptation by N. meningitidis from
growth on GC plates to growth in blood.
Echenique-Rivera et al. [12] have recently reported results
obtained by use of a similar co-cultivation model. They inoculated
blood samples with broth-grown meningococci in the early
exponential phase of growth. 637 genes were differentially
expressed during the course of 15–90 minutes co-cultivation.
Comparison of their gene list with ours established that 382 genes
were identified as differentially expressed over time in both studies
(see Table S3). Genes fHbp and nspA, mip (NMB0995) and katA,
encoding determinants of bloodstream survival and of virulence,
were found to be up-regulated at various time points in both
studies, suggesting their importance in this context, while in
neither study were genes involved in capsule biosynthesis and
transport found to be progressively up-regulated. However, there
are many discrepancies between the two studies. For example, the
expression of fur and other genes involved in the important
phenotype of iron uptake (tbpA, tbpB, lbpA, lbpB), as well as lctP, was
found to be up-regulated by Echenique-Rivera et al. [12], but
down-regulated in our work. We do not consider that such
differences invalidate either study, but they do provide an
important reminder that results must be interpreted with great
caution. Comparing the design of the two studies, there are
notable differences. Echenique-Rivera et al. [12] used a ten-fold
higher starting inoculum (10
8 CFU/ml blood), a strategy we have
Figure 6. Comparison of gene expression detected by microarray analysis and using real-time RT-PCR (TaqMan). RT-PCR results were
obtained using independent blood samples from donor A (TaqMan A) and donor B (TaqMan B) for co-cultivation experiments. Error bars were
calculated from three independent biological replicates.
doi:10.1371/journal.pone.0039718.g006
Figure 7. Detection of NMB0390 on the surface of meningococci by FACS. Meningococcal strain MC58 were recovered from human blood
(donor A) after 0, 90 and 240 min of cultivation.
doi:10.1371/journal.pone.0039718.g007
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infection. The bacterial environment in such circumstances must
however differ significantly from that encountered by organisms in
a non-immune, non-killer’s blood. Echenique-Rivera et al. [12]
included an RNA amplification step, which is believed to
introduce bias to the resulting transcriptomes [15].
Such differences will undoubtedly impact on findings in a major
way, but so too will undefined variables such as the nutritional
status of the blood donors (whether pre- or post-prandial, affecting
levels of lipids, glucose and other energy sources) and their iron
status. In short, inferences about host pathogen interaction and the
biology of virulence drawn on the basis of changing meningococ-
cal gene expression in the course of such experiments can be no
more than tentative, preliminary hypotheses should be further
assessed in a better defined setting. These cautionary remarks
notwithstanding, the value of pragmatic observations of gene
expression should not be underestimated. Surface-exposed anti-
genic structures which are apparently progressively up-regulated
in such experiments remain interesting targets for further study in
relation to vaccine discovery.
We identified nine genes apparently falling into this category –
their products predicted by the algorithms PSORT-b [37] to have
an outer membrane location, and progressively up-regulated
during bacterial growth in blood. Depite lacking conventional
signal sequences, the product of one of these, NMB0390, appeared
in confirmatory FACS experiments with mouse polyclonal serum
to be exposed at the meningococcal surface, and so potentially
accessible to vaccination-induced bactericidal antibody. Limita-
tions in the quality and quantity of the mouse polyclonal antiserum
available have meant that this supportive conclusion as to the
surface exposure of NMB0390 cannot at this stage be more than
tentative, and further experiments with new reagents, and with an
NMB0390 knockout strain, will be needed for confirmation.
In our transcriptome study, NMB0390 was only found to be
significantly upregulated at 40 min (Figure 6, Table S3), while a
major increase in surface expressed protein was found at 240 min
(Figure 7). We suggest that this apparent discrepancy reflects a
long half life of the NMB0390 protein compared to its coding
mRNA. In prokaryotes (as well as eukaryotes) the abundance of a
given mRNA and its coding product is not always correlated [38].
In addition, translational regulation can contribute to the
discordance in mRNA – protein abundance [38]. Interestingly,
NMB0390 has been predicted to be down-regulated in meningo-
cocci associated with epithelial cells [39] and also found to be
important for meningococcal survival in a mouse infection model
[40]. The nasopharynx is the site of (intense) immune selection
pressure, and accordingly the exposed domains of meningococcal
outer-membrane proteins such as the major porin PorA expressed
in this environment are notoriously variable [41,42]. We have
demonstrated in contrast a low level of sequence variation in
Figure 8. Schematic representation of amino acid variability of NMB0390 homologues from 25 N. meningitidis strains. Each vertical
bar indicates number of strains carrying different amino acid compared to the consensus sequence of NMB3090 homologues at a position indicated
by x-axis. Y-axis indicates number of strains. Strain information is provided in Table 6.
doi:10.1371/journal.pone.0039718.g008
Table 6. Comparison of amino acid sequence between
NMB0390 (752 aa) and its homologues from meningococcal
isolates.
Isolate Name Designation
1 ST
1
Sequence
3
identity (%)
MC58 B:15: P1.7,16–2 74 100
BZ169
2 B: P1.5–2,16 32 100
H44/76 B: P1.7,16 32 99
BZ133
2 B: P1.7,16 1 98
M01-240185
2 B: 2a: P1.5,10–8 11 97
2996
2 B: 2b: P1.2 540 97
BZ198
2 B: NT: 7–2,4 41 97
BZ232
2 B: NT; P1.5–2, 2–2 38 97
1000
2 B: P1.ND, ND 20 97
528
2 B: P1.5–1,10 18 97
CU385 B: 4: P1.15 33 100
M13399 B: nd: nd 2976 98
OX99.30304 B: nd: nd 44 98
M0579 B: NT: P1.5,2 43 97
961-5945 B: 2b: P1.21,16 153 97
ES14902 B: 2a: P1.5 11 97
M6190 B: 2va: P1.5,2 1988 97
M01-240013 B: NT: P1.22,9 275 97
Alpha710 B: P1.17,16–3: F5–5 136 98
NZ-05/33 B: 4: P1.7–2,4 42 98
M04-240196 B: NT: P1.19,15 269 98
M01-240355 B: 1: P1.22,14 213 98
M01-240149 B: 4: P1.7,4 41 98
G2136 B: nd: nd 8 97
961-5945 B: 2b: P1.21,16 153 97
1Meningococcal strain information is available at http://pubmlst.org/neisseria.
2From these meningococcal isolates DNA sequences were determined by
sequencing PCR-generated NMB0390 homologues in present study.
3Amino acid sequence were obtained either from deducing DNA sequences
(noted above) or from NCBI and references [50,51].
doi:10.1371/journal.pone.0039718.t006
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of expression in the nasopharynx. If its upregulation in the
bloodstream is confirmed in further studies, its candidacy for
inclusion in a multiple antigen vaccine to prevent serogroup B
meningococcal disease [33] would be importantly advanced.
Materials and Methods
Bacterial strains and growth conditions
N. meningitidis serogroup B strain MC58, used in blood co-
cultivation experiments, and 8 others used for NMB0390 sequence
comparison, are described in Table 6. Meningococcal strains were
routinely propagated on GC (gonococcal) agar (Difco) supple-
mented with 1% Vitox (sGC) at 37uCi n5 %C O 2 or in Mueller-
Hinton broth supplemented with 1% Vitox (Oxoid) at 37uCi na n
orbital incubator at 180 rpm.
Human blood co-cultivation model and meningococcal
RNA extractions
Human blood was collected from healthy adult volunteers
following Imperial College London research guidelines. Specific
approval for present study was given by Central Office for
Research Ethics Committees, St Mary’s NHS Trust, U.K. under
reference number 98/GB/157 (EC3570). Verbal informed con-
sent was obtained from healthy volunteers at the time of the
experiments. All volunteers have subsequently given written
acknowledgement of their verbal consent and these acknowledge-
ments have been filed along with a Note to File appended to the
Investigator Site File and signed by the Investigator, which
conforms to the ethics approval.
Human adult blood from donor A or B, both identified as
supporting growth of meningococcal strain MC58 in blood
(Figure 1B), were used. Due to greater availability, donor A’s
blood was used for both microarray and real-time PCR
experiments, while donor B’s blood was used only for real-time
PCR experiments. For co-cultivation experiments, MC58 was
inoculated from an overnight-incubated sGC plate onto fresh sGC
plates at a ratio of 10 colonies per 82-mm plate and incubated for
4 hours at 37uC with 5% CO2. In each experiment, fresh
heparinised blood (used within 20 min of being drawn) was placed
in a T25 tissue culture flask (BD Biosciences) and inoculated with
1–5610
7 CFU per ml blood of freshly grown MC58 suspended in
RPMI1640 (Invitrogen) and the mixture was incubated at 37uCi n
5% CO2 –enriched air with gentle rocking. In the majority of cases
5–6 ml blood was used for each co-incubation. At desired
incubation-time points (0, 20, 40, 60, 90 and 240 minutes)
samples (36100 ml per experiment) were removed for meningo-
coccal CFU enumeration and the remaining co-cultivation
contents were mixed with ice-cold 20 ml (46volume) RPMI1640
containing 5% saponin (Sigma) and incubated on ice for
10 minutes (a procedure which resulted in .95% lysis of human
cells, data not shown). Thereafter, 25 ml of RNAprotect bacterial
reagent (QIAGEN) was added and incubated at room temperature
for .5 minutes. The meningococci were collected by centrifuga-
tion at 3,500 g for 10 minutes and the resulting pellets suspended
in reagents for RNA extraction using FastRNA Pro Blue kit and
FastPrep FP120 (MP Biochemicals) according to the manufac-
tures’ protocols. RNA samples were further treated with DNase
(Invitrogen) and purified using an RNeasy kit (QIAGEN).
The quality of meningococcal total RNA and the level of
contamination with human total RNA was assessed using the
Bioanalyzer 2100 (Agilent) (Figure S1) and the quantity of total
RNA was confirmed using a NanoDrop 1000 (Thermo Scientific).
Biochemical tests of blood contents were performed by the
Clinical Biochemistry Unit at St Mary’s Hospital, Imperial College
Healthcare, London, using aliquots of blood samples from co-
cultivation experiments.
In addition, plasma from a killer’s (donor C) blood was added to
blood from donor A to a final 10% in co-cultivation experiments
with meningococcal inoculum 10
7 CFU/ml. At co-cultivation time
points 90 min samples were plated out for meningococcal CFU
enumeration (Figure 1C). The killer’s blood was also used to
characterise bactericidal activity with different meningococcal
inoculums (10
9 and 10
7 CFU/ml) and meningococcal CFU was
obtained at co-cultivation time points 45, 90 and 240 min
(Figure 1A).
DNA microarray hybridization and analysis
Labelling of RNA and DNA samples (5 mg total RNA, 0.5 mg
gDNA from strain MC58), microarray hybridization and washing
were carried out in accordance with a method previously
published [43]. The Pan-Neisseria array slides have been
described previously [44]. The array design is available in
BmG@Sbase (accession no. E-BUGS-75; http:// bugs.sgul.a-
c.uk/E-BUGS-75) and also ArrayExpress (accession No.
EBUGS-75). Each array slide was co-hybridized with one of the
Cy5-labelled experimental RNA samples and Cy3-labelled gDNA
(universal reference). The resulting microarray slides were scanned
using the GenePix-4000B (Axon) and images analysed with
GenePix Pro 6.0 (Axon).
Linear models for microarray data [45] were used to produce
differentially expressed gene lists. Background-subtracted spot
intensities from hybridized Cy5 labels (signal channel) were
divided by the intensities from hybridized Cy3 labels (reference
channel). Per slide normalization was performed using median
log2 ratios. The normalized gene values combined from the
biological replicates (n=5 or 6) of each later time point (20, 40, 60,
90 and 240 min) were compared with that of time zero using
linear model implemented in Limma [45] to identify differentially
expressed genes with a cut-off value of more than 1.5 fold change
(0.585 in log2) and p,0.01 adjusted with multiple testing based on
Benjamini and Hochberg step down for false discovery rate (FDR)
correction [46].
GSEA [28] was performed to identify significantly differentially
regulated gene groups according to TIGR functional grouping
(www.tigr.org). There was no significant group found in the data
for co-cultivation time points 90 min and 240 min.
Correlation of gene expression profiles (slide-to-slide compari-
son) was calculated using the Find Similar Sample feature in
GeneSpring G67.3 software (Agilent). The gene expression profile
of one slide (e.g. T=0min biological replicate 1) was set as the
baseline pattern, and gene expression pattern of any other slide
(any replicate of a time point) was compared against that pattern.
A similarity score was assigned to each sample based on the degree
to which its overall gene expression pattern resembles the baseline
pattern.
Fully annotated microarray data have been deposited in
BmG@Sbase (accession number E-BUGS-121; http://bugs.sgul.
ac.uk/E-BUGS-121) and also ArrayExpress (accession number E-
BUGS-121), which is in compliance with MIAME.
Quantitative real-time RT-PCR
RNA samples from three fresh biological replicates were
prepared as described above using blood from donors A and B,
and were reverse-transcribed to first strand cDNA using Super-
script III and random primers (Invitrogen). Real-time PCR was
performed as described previously [43] using TaqMan technolo-
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system (Applied Biosystems). The primers were designed and
manufactured using Assay-by-Design (Applied Biosystems) and are
listed in Table S4. Reporter dye and quencher were FAM and
NFQ, respectively. We used 10 ng total RNA per reaction. The
reference gene was 16S rRNA. Statistical analysis was based on
Livak and Schmittgen [47] and detailed statistical formulations are
described in Applied Biosystems’ User Bulletin no. 2 (P/N
4303859).
Flow cytometry analysis
N. meningitidis strain MC58 collected from blood co-cultivation
experiments at T=0, 90 and 240min were suspended in PBS/
1%BSA for flow cytometry analysis and diluted to give 10
6 CFU
per reaction, final volume of 40 ml, in wells of 96-well plates. The
bacteria were sequentially incubated with firstly antibodies diluted
1:10 (mouse anti-NMB0390, mouse serum immunised with PBS,
or no serum) and secondly antibodies diluted 1:100 (FITC
conjugated anti-mouse serum, from Sigma) at 37uC for 30 minutes
with gentle agitation. Bacteria were washed twice with PBS (final
volume 190 ml per well) at the end of each incubation and
collected by centrifugation at 3,500 g for 10 minutes. After the
final wash each bacterial sample were suspended in 150 mlo f
PBS/0.25% formaldehyde and incubated at 4uC for 16 hours.
The resulting samples were analysed using a flow cytometer
CyAn ADP (Dako) with 10
4 events taken for each sample and
Summit v4.3 software (Dako). Meningococcal surface protein
specific antibodies together with anti-PBS sera (control sera) were
kind gifts from Dr. Barchra Rokbi of Sanofi Pasteur, Lyon, France.
PCR Generating NMB0390 homologues, sequencing and
comparison
Genomic DNA was prepared from a collection of meningococ-
cal strains (Table 6) using QIAamp DNA mini kit (QIAGEN).
DNA templates for sequencing were generated by PCR using
genomic DNA, HotStar kit (QIAGEN) with 10% DMSO (Sigma)
added and primers: TCGGTGTGCGTTTCAATGTG and
GTTGTTGTAGTTGTCCAAGTCCAGG at 1 mM each. PCR
reactions were performed in an DNA Engine (MJ Research) as
306(95uC, 30 sec; 52uC, 1 min; 72uC, 3min).
Sequencing products were generated using BigDye v3.1
reaction kit (Applied Biosystems) and primer
TGTCGTTTTTACGGCGGGTC, in addition to the two
primers used in PCR reaction in order to obtain sequencing on
both DNA strands. The products were run on an ABI3730XL
sequencer (Applied Biosystems) at Sequencing unit, Department of
Zoology, University of Oxford. The resulting sequencing files were
checked manually.
The amino acid sequences were compared using ClustalW
programme [48]. Protein subcellular localization was predicted
using PSORTb programme [37].
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Figure S1 Analysis of meningococcal total RNA obtained
from co-cultivation experiments using Bioanalyzer 2100.
16S and 23S represent meningococcal RNA. 18S and 28S
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